Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Zhouyu Zhu; Tao Yu; Ying Chai

doi:10.18632/oncotarget.28313

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

PDF | How to cite

Oncotarget. 2022; 13:1271-1271. https://doi.org/10.18632/oncotarget.28313

Metrics: PDF 406 views | ?

Zhouyu Zhu¹, Tao Yu¹ and Ying Chai¹

¹Department of Thoracic Surgery, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Published: November 17, 2022

Copyright: © 2022 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: Patient consent was obtained from the patient.

Original article: Oncotarget. 2016; 7:81969–81971. DOI: https://doi.org/10.18632/oncotarget.13046

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28313

Publication Alerts

Addendum:

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles